Drug Type AAV based gene therapy |
Synonyms |
Target |
Mechanism Gamma-sarcoglycan gene transference |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Muscular Dystrophies, Limb-Girdle | Preclinical | US | - | |
Muscular Dystrophies, Limb-Girdle | Preclinical | US | Myonexus Therapeutics, Inc.Startup | - |